Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Clinical Therapeutics|August 25, 2005
Therapeutic options for pneumococcal pneumonia in TurkeySerkan Oncu, Hakan Erdem, Alaaddin PahsaScandinavian Journal of Infectious Diseases|May 20, 2003
Symptomatic intestinal amoebiasis and climatic parametersHakan Erdem, Selim Kiliç, Esref Cinar, et al.The Annals of Otology, Rhinology, and Laryngology|September 30, 2005
Effect of climate on the bacteriology of chronic suppurative otitis mediaAltan Yildirim, Hakan Erdem, Selim Kilic, et al.Vaccine|August 7, 2002
Assessment of the antibody response in 110 healthy individuals who have been subject to Vi capsular polysaccharide vaccineUfuk Dizer, Levent Görenek, Ozgür Güner, et al.Emerging Infectious Diseases|June 18, 2004
Neisseria meningitidis W135, TurkeyLevent Doganci, Mehmet Baysallar, Mehmet Ali Saracli, et al.The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 13, 2004
Identification of yeasts in public hospital primary care patients with or without clinical vaginitisHakan Erdem, Meral Cetin, Timucin Timuroglu, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 31, 2006
Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective studyMehmet Can, Bulent Ahmet Beşirbellioglu, Ismail Yasar Avci, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 18, 2003
Minimal change disease in a patient receiving IFN-alpha therapy for chronic hepatitis C virus infectionUfuk Dizer, Can Murat Beker, Izzet Yavuz, et al.Chemotherapy|February 22, 2005
The effect of the doxycycline-rifampicin and levamisole combination on lymphocyte subgroups and functions of phagocytic cells in patients with chronic brucellosisUfuk Dizer, Levent Hayat, Can Murat Beker, et al.Mikrobiyoloji Bulteni|October 3, 2009
[Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress]Ali Acar, Levent Görenek, Ahmet Aydin, et al.Pageof 2